SARS-CoV2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme
-
- Overview
-
- Research
-
- Identity
-
- Other
-
- View All
-
Overview
published proceedings
-
ACS Medicinal Chemistry Letters
author list (cited authors)
-
Blankenship, L. R., Yang, K. S., Vulupala, V. R., Alugubelli, Y. R., Khatua, K., Coleman, D., ... Liu, W. R.
complete list of authors
-
Blankenship, Lauren R||Yang, Kai S||Vulupala, Veerabhadra R||Alugubelli, Yugendar R||Khatua, Kaustav||Coleman, Demonta||R., Xinyu||Sankaran, Banumathi||Cho, Chia-Chuan D||Ma, Yuying||Neuman, Benjamin W||Xu, Shiqing||Liu, Wenshe Ray
publisher
published in
Research
keywords
-
34 Chemical Sciences
-
3404 Medicinal And Biomolecular Chemistry
-
3405 Organic Chemistry
-
5 Development Of Treatments And Therapeutic Interventions
-
5.1 Pharmaceuticals
-
Biodefense
-
Prevention
-
Vaccine Related
Identity
Digital Object Identifier (DOI)
Other
URL
-
http://dx.doi.org/10.1021/acsmedchemlett.4c00146